Burning Rock Biotech (BNR) vs Exagen (XGN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Burning Rock Biotech (BNR) has outperformed Exagen (XGN) over the past year, gaining 70.8% versus a loss of 25.6%. Over five years, XGN leads with a -35.3% price change compared with -89.4% for BNR. Exagen is the larger company by market cap ($204.1 million vs $166.8 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BNR | XGN |
|---|---|---|
| Share price | $15.82 | $8.43 |
| Market cap | $166.84M | $204.10M |
| 1-day change | +5.47% | +3.12% |
| YTD return | -24.57% | +34.38% |
| 1-year return | +70.79% | -25.59% |
| 5-year return | -89.42% | -35.31% |
| EPS (TTM) | $-0.80 | $-0.81 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $41.72 | $12.23 |
| 52-week low | $6.79 | $2.59 |
| Distance from 52-week high | -62.08% | -31.11% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +20.36% |
| Average volume | 28.59K | 331.27K |
| Shares outstanding | 8.81M | 24.23M |
| Employees | 667 | 216 |
| Sector | Health Care | Health Care |
| Industry | Medical Specialities | Medical Specialities |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- BNR has outperformed XGN by 96.4 percentage points over the past year.
About Burning Rock Biotech
BNR stock →Burning Rock Biotech Limited develops and sells cancer therapy selection tests in the People's Republic of China and the United States. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services.
Health Care · Medical Specialities · 667 employees
About Exagen
XGN stock →Exagen Inc. designs, develops, and commercializes various testing products under the AVISE brand in the United States.
Health Care · Medical Specialities · 216 employees
BNR vs XGN FAQ
Which is bigger, Burning Rock Biotech or Exagen?
Exagen (XGN) is larger, with a market capitalization of $204.10M compared with $166.84M for Burning Rock Biotech (BNR).
Which stock has performed better over the past year, BNR or XGN?
BNR returned +70.79% over the past 12 months, compared with -25.59% for XGN (price return, excluding dividends). Past performance does not predict future results.
Are Burning Rock Biotech and Exagen in the same industry?
Yes. Both are classified in the Medical Specialities industry within the Health Care sector.